Pilot study to identify missed opportunities for prevention of childhood tuberculosis.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 28 08 2021
accepted: 19 06 2022
revised: 03 03 2022
pubmed: 1 7 2022
medline: 25 8 2022
entrez: 30 6 2022
Statut: ppublish

Résumé

Tuberculosis (TB) in exposed children can be prevented with timely contact tracing and preventive treatment. This study aimed to identify potential barriers and delays in the prevention of childhood TB in a low-incidence country by assessing the management of children subsequently diagnosed with TB. A pilot retrospective cohort study included children (< 15 years) treated for TB between 2009 and 2016 at a tertiary care hospital in Berlin, Germany. Clinical data on cases and source cases, information on time points of the diagnostic work up, and preventive measures were collected and analyzed. Forty-eight children (median age 3 years [range 0.25-14]) were included; 36 had been identified through contact tracing, the majority (26; 72.2%) being < 5 years. TB source cases were mostly family members, often with advanced disease. Thirty children (83.3%) did not receive prophylactic or preventive treatment, as TB was already prevalent when first presented. Three cases developed TB despite preventive or prophylactic treatment; in three cases (all < 5 years), recommendations had not been followed. Once TB was diagnosed in source cases, referral, assessment, TB diagnosis, and treatment were initiated in most children in a timely manner with a median duration of 18 days (interquartile range 6-60, range 0-252) between diagnosis of source case and child contact (information available for 35/36; 97.2%). In some cases, notable delays in follow-up occurred. Prompt diagnosis of adult source cases appears to be the most important challenge for childhood TB prevention. However, improvement is also needed in the management of exposed children. • Following infection with Mycobacterium tuberculosis, young children have a high risk of progression to active and severe forms of tuberculosis (TB). • The risk of infection and disease progression can be minimized by prompt identification of TB-exposed individuals and initiation of prophylactic or preventive treatment. • We could show that there are avoidable time lags in diagnosis in a relevant proportion of children with known TB exposure. • Delayed diagnosis of adult source cases, losses in follow-up examinations, and delay in referral to a specialized TB clinic of TB-exposed children, especially among foreign-born children, appear to be the main issue in this German pediatric study cohort.

Identifiants

pubmed: 35771355
doi: 10.1007/s00431-022-04537-1
pii: 10.1007/s00431-022-04537-1
pmc: PMC9395448
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3299-3307

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s).

Références

Am J Respir Crit Care Med. 2014 Nov 1;190(9):1044-52
pubmed: 25265362
Trop Med Int Health. 2012 Oct;17(10):1264-73
pubmed: 22862994
Pediatr Radiol. 2004 Nov;34(11):886-94
pubmed: 15300340
Lancet Infect Dis. 2019 Mar;19(3):e96-e108
pubmed: 30322790
Euro Surveill. 2009 Mar 19;14(11):
pubmed: 19317977
JAMA. 1984 Mar 9;251(10):1283-5
pubmed: 6366257
Int J Tuberc Lung Dis. 2004 Apr;8(4):392-402
pubmed: 15141729
BMC Pulm Med. 2017 Dec 13;17(1):202
pubmed: 29237451
BMJ Open Respir Res. 2019 Oct 15;6(1):e000468
pubmed: 31673368
Int J Tuberc Lung Dis. 2011 Dec;15(12):1630-7
pubmed: 22118170
Clin Infect Dis. 2015 Oct 15;61Suppl 3:S179-87
pubmed: 26409281
Pneumologie. 2011 Jun;65(6):359-78
pubmed: 21560113
Am J Respir Crit Care Med. 2021 Jan 15;203(2):168-174
pubmed: 33197210
Public Health Action. 2021 Jun 21;11(2):91-96
pubmed: 34159069
Eur Respir J. 2014 Sep;44(3):714-24
pubmed: 25063246
Eur J Pediatr. 2019 Sep;178(9):1449-1467
pubmed: 31240389
Pneumologie. 2017 Oct;71(10):629-680
pubmed: 29017219
Clin Infect Dis. 2007 Sep 15;45(6):715-22
pubmed: 17712755
Am J Epidemiol. 2017 Jun 15;185(12):1327-1339
pubmed: 28982226
Expert Rev Anti Infect Ther. 2018 Apr;16(4):359-365
pubmed: 29465259
Emerg Infect Dis. 1995 Oct-Dec;1(4):115-23
pubmed: 8903180
Pediatrics. 2000 Dec;106(6):E75
pubmed: 11099618
Eur Respir J. 2015 Dec;46(6):1563-76
pubmed: 26405286
Lancet. 2020 Mar 21;395(10228):973-984
pubmed: 32199484
Scand J Infect Dis. 2012 Jan;44(1):29-36
pubmed: 21923629

Auteurs

Cornelia Feiterna-Sperling (C)

Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. cornelia.feiterna-sperling@charite.de.

Janine Thoulass (J)

Health Protection Scotland, Glasgow, Scotland.
Postgraduate Training for Applied Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany affiliated to the European Programme for Intervention Epidemiology Training, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

Renate Krüger (R)

Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Walter Haas (W)

Respiratory Infections Unit, Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Barbara Hauer (B)

Respiratory Infections Unit, Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH